Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 5 of 5 publications.

Dardis GJ, Wang J, Simon JM, Wang GG, Baldwin AS. An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer. iScience. 2023 Jun 14;26(7):107115. doi: 10.1016/j.isci.2023.107115

Dardis GJ, Wang J, Simon JM, Wang GG, Baldwin AS. EZH2 co-activates NF-KappaB targets with RelA in a PRC2-independent manner in TNBC cells. Poster presented at the 6th Cold Spring Harbor Laboratory Meeting on Epigenetics & Chromatin; September 20, 2022. Cold Spring Harbor, NY.

Dardis GJ, Baldwin AS. EZH2 as a transcriptional activator of NF-kappaB in TNBC. Poster presented at the Virtual 5th Cold Spring Harbor Laboratory Meeting on Epigenetics & Chromatin; September 15, 2020.

Chung AH, Leisner TM, Dardis GJ, Bivins MM, Keller AL, Parise LV. CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death. Cancer Cell Int. 2019 Feb 4;19(26). doi: 10.1186/s12935-019-0740-2

Dardis G, Tryon R, Ton Q, Johnson SL, Lovine MK. Cx43 suppresses evx1 expression to regulate joint initiation in the regenerating fin. Dev Dyn. 2017 Sep;246(9):691-9. doi: 10.1002/dvdy.24531